556 related articles for article (PubMed ID: 33901462)
1. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
[TBL] [Abstract][Full Text] [Related]
2. p66Shc regulates podocyte autophagy in high glucose environment through the Notch-PTEN-PI3K/Akt/mTOR pathway.
Zheng D; Tao M; Liang X; Li Y; Jin J; He Q
Histol Histopathol; 2020 Apr; 35(4):405-415. PubMed ID: 31650524
[TBL] [Abstract][Full Text] [Related]
3. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
[TBL] [Abstract][Full Text] [Related]
4. Tripterygium glycoside suppresses epithelial‑to‑mesenchymal transition of diabetic kidney disease podocytes by targeting autophagy through the mTOR/Twist1 pathway.
Tao M; Zheng D; Liang X; Wu D; Hu K; Jin J; He Q
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165172
[TBL] [Abstract][Full Text] [Related]
5. Wogonin protects glomerular podocytes by targeting Bcl-2-mediated autophagy and apoptosis in diabetic kidney disease.
Liu XQ; Jiang L; Li YY; Huang YB; Hu XR; Zhu W; Wang X; Wu YG; Meng XM; Qi XM
Acta Pharmacol Sin; 2022 Jan; 43(1):96-110. PubMed ID: 34253875
[TBL] [Abstract][Full Text] [Related]
6. Podocyte Injury in Diabetic Kidney Disease in Mouse Models Involves TRPC6-mediated Calpain Activation Impairing Autophagy.
Salemkour Y; Yildiz D; Dionet L; 't Hart DC; Verheijden KAT; Saito R; Mahtal N; Delbet JD; Letavernier E; Rabant M; Karras A; van der Vlag J; Nijenhuis T; Tharaux PL; Lenoir O
J Am Soc Nephrol; 2023 Nov; 34(11):1823-1842. PubMed ID: 37678257
[TBL] [Abstract][Full Text] [Related]
7. Effect of liraglutide on the Janus kinase/signal transducer and transcription activator (JAK/STAT) pathway in diabetic kidney disease in db/db mice and in cultured endothelial cells.
Zitman-Gal T; Einbinder Y; Ohana M; Katzav A; Kartawy A; Benchetrit S
J Diabetes; 2019 Aug; 11(8):656-664. PubMed ID: 30575282
[TBL] [Abstract][Full Text] [Related]
8. Tripterygium glycoside protects diabetic kidney disease mouse serum-induced podocyte injury by upregulating autophagy and downregulating β-arrestin-1.
Zhan H; Jin J; Liang S; Zhao L; Gong J; He Q
Histol Histopathol; 2019 Aug; 34(8):943-952. PubMed ID: 30839094
[TBL] [Abstract][Full Text] [Related]
9. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
[TBL] [Abstract][Full Text] [Related]
10. Suppressors of cytokine signaling abrogate diabetic nephropathy.
Ortiz-Muñoz G; Lopez-Parra V; Lopez-Franco O; Fernandez-Vizarra P; Mallavia B; Flores C; Sanz A; Blanco J; Mezzano S; Ortiz A; Egido J; Gomez-Guerrero C
J Am Soc Nephrol; 2010 May; 21(5):763-72. PubMed ID: 20185635
[TBL] [Abstract][Full Text] [Related]
11. Krüppel‑like factor 4 ameliorates diabetic kidney disease by activating autophagy via the mTOR pathway.
Gong J; Zhan H; Li Y; Zhang W; Jin J; He Q
Mol Med Rep; 2019 Oct; 20(4):3240-3248. PubMed ID: 31432191
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
[TBL] [Abstract][Full Text] [Related]
13. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease.
Fujimoto D; Kuwabara T; Hata Y; Umemoto S; Kanki T; Nishiguchi Y; Mizumoto T; Hayata M; Kakizoe Y; Izumi Y; Takahashi S; Mukoyama M
FASEB J; 2020 Nov; 34(11):15577-15590. PubMed ID: 32996639
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation end-products suppress autophagic flux in podocytes by activating mammalian target of rapamycin and inhibiting nuclear translocation of transcription factor EB.
Zhao X; Chen Y; Tan X; Zhang L; Zhang H; Li Z; Liu S; Li R; Lin T; Liao R; Zhang Q; Dong W; Shi W; Liang X
J Pathol; 2018 Jun; 245(2):235-248. PubMed ID: 29570219
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.
Xiao T; Guan X; Nie L; Wang S; Sun L; He T; Huang Y; Zhang J; Yang K; Wang J; Zhao J
Mol Cell Biochem; 2014 Sep; 394(1-2):145-54. PubMed ID: 24850187
[TBL] [Abstract][Full Text] [Related]
16. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
17. JAK inhibition and progressive kidney disease.
Brosius FC; He JC
Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):88-95. PubMed ID: 25415616
[TBL] [Abstract][Full Text] [Related]
18. Wogonin upregulates SOCS3 to alleviate the injury in Diabetic Nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway.
Liu Y; Zhang M; Zeng L; Lai Y; Wu S; Su X
Mol Med; 2024 Jun; 30(1):78. PubMed ID: 38844873
[TBL] [Abstract][Full Text] [Related]
19. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions.
Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Zhou Y; Lu Y; Tang W; Yi F
J Mol Med (Berl); 2019 Nov; 97(11):1507-1520. PubMed ID: 31402399
[TBL] [Abstract][Full Text] [Related]
20. miR-4645-3p attenuates podocyte injury and mitochondrial dysfunction in diabetic kidney disease by targeting Cdk5.
Zhang Y; Xia S; Tian X; Yuan L; Gao Y; Liu D; Qi H; Wang S; Liu Z; Li Y; Zhao Z; Liu W
FASEB J; 2024 May; 38(10):e23668. PubMed ID: 38742811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
